Oncology Institute Inc.
TOI | NASDAQ
$5.13
-$1.26 (-19.72%)
At close: Aug 03, 2026, 04:00 PM ET
Market Data
Market Cap $512.91M
Enterprise Value $496.43M
Beta 0.42
Average Volume 1.92M
Shares Outstanding (Diluted) 1.03B
Shares Change YoY 10.54%
Institutional Ownership 3.91%
Exchange NASDAQ
ISIN US68236X1000
Price Performance
Price Change 1M N/A
Price Change 3M -12.9%
Price Change 6M 55.5%
Price Change YTD 39.8%
Price Change 1Y 29.2%
Price Change 3Y 231.0%
Price Change 5Y -48.4%
1M CAGR (ann.) 3.2%
1Y CAGR (ann.) 38.6%
5Y CAGR (ann.) -12.3%
All-Time CAGR -9.7%
Valuation
PE Ratio -18.32
Forward PE N/A
PEG Ratio -0.19
Forward PEG 0.24
PS Ratio 0.87
Forward PS 0.60
PB Ratio -20.59
P/FCF Ratio -156.09
P/Adj. FCF Ratio -83.09
P/OCF Ratio N/A
EV/Sales 0.85
EV/EBIT -23.94
EV/EBITDA -26.77
EV/FCF -151.07
Earnings Yield -5.5%
FCF Yield -0.6%
Adj. FCF Yield -1.2%
Financial Health
Net Cash $16.49M
Total Debt $24.61M
Cash & Short-Term Investments $41.09M
Total Assets $178.23M
Current Ratio 1.36
Quick Ratio 1.15
Debt / Equity Ratio -0.99
Debt / EBITDA -1.33
Debt / FCF -7.49
OCF / Debt 0.01
Interest Coverage -3.42
Altman Z-Score 2.43
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 15.4%
Operating Profit Margin -4.4%
EBITDA Margin -3.7%
Net Profit Margin -6.2%
FCF Margin -0.6%
Adj. FCF Margin -1.1%
SBC / Revenue 0.5%
SBC Impact (per share) -87.9%
Returns
Return on Assets -20.4%
Return on Equity 209.8%
Return on Invested Capital -28.8%
Return on Capital Employed -31.3%
Return on Tangible Assets -22.5%
Historical Growth (CAGR)
Revenue CAGR 3Y 26.1%
Revenue CAGR 5Y 24.7%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 43.7%
EPS CAGR 5Y -6.8%
EPS CAGR 10Y N/A
FCF CAGR 3Y 104.2%
FCF CAGR 5Y 42.9%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 5
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Aug 6, 2026
EPS Estimate (next Q) -$0.07
EPS Growth Est (next Q) -50.0%
Revenue Est (next Q) $155.28M
Revenue Growth Est (next Q) 29.6%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $8.67
Price Target Upside 69.0%
Cash Flow
Operating Cash Flow $328K
Free Cash Flow $-3.29M
Adj. Free Cash Flow $-6.17M
FCF Per Share -$0.03
OCF Per Share $0.00
OCF/S Ratio 0.1%
Income Statement
Revenue $587.24M
Gross Profit $63.38M
Operating Income $-26.09M
EBITDA $-18.54M
Net Income $-36.29M
EPS (Diluted) -$0.28
Revenue / Employee $916.14K
Profit / Employee $-56.62K
Employees 641
Add to Watchlist
Select watchlists to add or remove TOI